Delfi Diagnostics is a biotechnology company developing high-performance, low-cost liquid biopsy tests for the early detection of cancer. The company utilizes a proprietary platform called fragmentomics, which applies machine learning to analyze patterns of DNA fragments in the bloodstream. By focusing on the structural biology of the genome rather than specific mutations, Delfi aims to make cancer screening more accessible and scalable globally.
Brand Authority Index (BAI): 72/100
Archetype: Challenger
Category: Biotechnology
https://optimly.ai/brand/delfi-diagnostics
Last analyzed: April 10, 2026
Founded: 2019
Headquarters: Baltimore, Maryland, USA